1. Home
  2. AYTU vs TOPS Comparison

AYTU vs TOPS Comparison

Compare AYTU & TOPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AYTU
  • TOPS
  • Stock Information
  • Founded
  • AYTU N/A
  • TOPS 2000
  • Country
  • AYTU United States
  • TOPS Greece
  • Employees
  • AYTU N/A
  • TOPS N/A
  • Industry
  • AYTU Biotechnology: Pharmaceutical Preparations
  • TOPS Marine Transportation
  • Sector
  • AYTU Health Care
  • TOPS Consumer Discretionary
  • Exchange
  • AYTU Nasdaq
  • TOPS Nasdaq
  • Market Cap
  • AYTU 23.0M
  • TOPS 27.1M
  • IPO Year
  • AYTU N/A
  • TOPS 2004
  • Fundamental
  • Price
  • AYTU $2.10
  • TOPS $5.91
  • Analyst Decision
  • AYTU Strong Buy
  • TOPS
  • Analyst Count
  • AYTU 3
  • TOPS 0
  • Target Price
  • AYTU $9.17
  • TOPS N/A
  • AVG Volume (30 Days)
  • AYTU 62.6K
  • TOPS 9.4K
  • Earning Date
  • AYTU 11-13-2025
  • TOPS 11-14-2025
  • Dividend Yield
  • AYTU N/A
  • TOPS N/A
  • EPS Growth
  • AYTU N/A
  • TOPS N/A
  • EPS
  • AYTU N/A
  • TOPS 2.30
  • Revenue
  • AYTU $66,382,000.00
  • TOPS $87,872,000.00
  • Revenue This Year
  • AYTU N/A
  • TOPS $9.90
  • Revenue Next Year
  • AYTU $29.12
  • TOPS N/A
  • P/E Ratio
  • AYTU N/A
  • TOPS $2.60
  • Revenue Growth
  • AYTU 1.84
  • TOPS 4.77
  • 52 Week Low
  • AYTU $0.95
  • TOPS $5.00
  • 52 Week High
  • AYTU $2.82
  • TOPS $11.47
  • Technical
  • Relative Strength Index (RSI)
  • AYTU 41.10
  • TOPS 57.23
  • Support Level
  • AYTU $2.01
  • TOPS $5.85
  • Resistance Level
  • AYTU $2.18
  • TOPS $6.11
  • Average True Range (ATR)
  • AYTU 0.13
  • TOPS 0.20
  • MACD
  • AYTU -0.02
  • TOPS -0.01
  • Stochastic Oscillator
  • AYTU 50.98
  • TOPS 70.00

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.

About TOPS TOP Ships Inc.

TOP Ships Inc owns tanker vessels throughout the world. The Company is an international owner and operator of modern, fuel-efficient eco tanker vessels focusing on the transportation of crude oil, petroleum products (clean and dirty), and bulk liquid chemicals. It generates revenue from the Time Charter agreements.

Share on Social Networks: